Skip to main content

Animations

MJFF Publications

1901 - 1910 of 9118 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2023
  • 2019
  • 2016
  • 2020
  • 2019
  • 2015
  • 2017
  • 2017
  • Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    2022
    Summary Details
    RESTRICTED
    Title: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 at a glance
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.259724
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Longitudinal dysregulation of long non-coding RNAs in Parkinson’s disease
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702231198078
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Abstract
    Journal Name: Brain and Neuroscience Advances
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/2398212819855490
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0072-9
    Citation Count: 290
  • Summary Details
    OPEN
    Title: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease
    Journal Name: Journal of Medical Genetics
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jmedgenet-2019-106283
    Citation Count: 71
  • Summary Details
    RESTRICTED
    Title: Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2015-311827
    Citation Count: 128
  • Summary Details
    OPEN
    Title: Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2017-316213
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2016-315023
    Citation Count: 112
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.